跳至主要内容
临床试验/NCT05400239
NCT05400239招募中不适用

SOTO Study: Prospective Study to Correlate the Treatment Sensitivity of Patient-derived Organoids With Clinical Outcomes in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients

Guy's and St Thomas' NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Successful Organoids

研究概览

简要总结

In this study, we aim to assess whether Patient Derived Organoids can be used to predict treatment sensitivity in HNSCC patients.

详细描述

This is a prospective observation study to generate patient-derived organoids from patients' samples to assess treatment response and to correlate with patients' treatment outcomes and to collect preliminary data on the ability of PDOs to predict patients' treatment response and whether their radiosensitivity and chemosensitivity can be correlated with their survival outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with head and neck squamous cell carcinoma (including oral cavity, oropharynx, paranasal sinuses, hypopharynx or larynx) undergoing curative treatment (primary surgery or radiotherapy) or presenting with recurrent or metastatic cancers
  • Age > 18 years old

排除标准

  • Patients unable to give informed consent e.g. mental disability or vulnerable adults

结局指标

主要结局

Successful Organoids

时间窗: 1 Year

To assess the percentage of successful generated organoids from tissues in head and neck cancer patients

次要结局

  • Sensitivity(1 Year)
  • Treatment Outcome(1 Year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

SOTO: Treatment Sensitivity of Organoids to Predict... | 临床试验